يعرض 1 - 10 نتائج من 98 نتيجة بحث عن '"recombinant strains"', وقت الاستعلام: 0.84s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المصدر: Epidemiology and Vaccinal Prevention; Том 22, № 4 (2023); 4-11 ; Эпидемиология и Вакцинопрофилактика; Том 22, № 4 (2023); 4-11 ; 2619-0494 ; 2073-3046

    وصف الملف: application/pdf

    العلاقة: https://www.epidemvac.ru/jour/article/view/1847/950Test; Johansson EL, Wassén L, Holmgren J, Jertborn M, Rudin A. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect Immun. 2001;69(12):7481–6. doi:10.1128/IAI.01403-13; Ma Y., Luo Y., Huang X., Song F., Liu G. Construction of Bifidobacterium infantis as a live oral vaccine that expresses antigens. Microbiology. 2012;158: 498–504. doi:10.1099/mic.0.049932-0.; De Azevedo M, Karczewski J, Lefévre F, et al. In vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin. BMC Microbiol. 2012; 12: 299. DOI:10.1186/1471-2180-12-299; Laiño J., Villena J., Zelaya H., Moyano R.O., Salva S., Alvarez S., Suvorov A. Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to streptococcus pneumoniae infection. PLoS ONE. 2018;13(11):e0206661. doi:10.1371/jornal.pone0206661; Грабовская К. Б., Леонтьева Г. Ф., Мерингова Л. Ф. и др. Протективные свойства некоторых поверхностных белков стрептококков группы В. Журн. микробиол., 2007;5:44 –50. /Grabovskaya K., Leontieva G., Meringova L., et al. Protective properties of some surface proteins of the streptococcus group B. Journal of microbiology. 2007;5:44–50 ( in Russ.).; Suvorov A., Dukhovlinov I., Leontieva G., et al. Chimeric protein PSPF, a potential vaccine for prevention Streptococcus pneumonia infection. Journal of Vaccines and Vaccination. 2015;6:6. doi 2157-7560/1000304; Mojgani N., Shahali Y., Dadar M. Immune modulatory capacity of probiotic lactic acid bacteria and applications in vaccine development. Benef Microbes. 2020;11(3):213– 226. doi:10.3920/BM2019.0121.; Tarasova E., Yermolenko E., Donets V, et al. The influence of probiotic Enterococcus faecium strain L5 on the microbiota and cytokines expression in rats with. dysbiosis induced by antibiotics. Beneficial Microbs.2010; 1: 265–270.doi:3920%7CBM2010.0008; Karaseva A, Tsapieva A, Pachebat J, Suvorov A. Draft Genome Sequence of Probiotic Enterococcus faecium Strain L-3. Genome Announc. 2016; 28;4(1):e01622–15. doi:10.1128/genomeA.01622-15. PMID: 26823581; PMCID: PMC4732334; Davies JR, Svensäter G, Herzberg MC. Identification of novel LPXTG-linked surface proteins from Streptococcus gordonii. Microbiology (Reading). 2009; 155(6):1977–1988. doi:10.1099/mic.0.027854-0; Pinkston K.L., Singh K.V., Gao P., et al. Targeting pili in enterococcal pathogenesis. Infect.Immun.2014;82(4):1540–1547. doi:10.1128/IAI.01403-13; Gupalova T., Leontieva G., Kramskaya T., et al. Development of experimental GBS vaccine for mucosal immunization. PLoS One. 2018;13(5):e0196564. doi:10.1371/journal.pone.0196564; Gupalova T., Leontieva G., Kramskaya T., et al. Development of experimental pneumococcal vaccine for mucosal immunization. PLoS One. 2019;28;14(6):e0218679. doi:10.1371/journal.pone.0218679. PMID: 31251760; PMCID: PMC6599147.; Desheva Y., Leontieva G., Kramskaya T., et al. Developing a Live Probiotic Vaccine Based on the Enterococcus faecium L3 Strain Expressing Influenza Neuraminidase. Microorganisms. 2021; 27;9(12):2446. doi:10.3390/microorganisms9122446; Desheva Y., Leontieva G., Kramskaya T., et al. Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model. Virulence. 2022;13(1):558–568. doi:10.1080/21505594.2022.2049496; Mezhenskaya D, Isakova-Sivak I, Gupalova T, et al. A Live Probiotic Vaccine Prototype Based on Conserved Influenza a Virus Antigens Protect Mice against Lethal Influenza Virus Infection. Biomedicines. 2021;21;9(11):1515. doi:10.3390/biomedicines9111515; Suvorov A, Gupalova T, Desheva Y, et al. Construction of the Enterococcal Strain Expressing Immunogenic Fragment of SARS-Cov-2 Virus. Front Pharmacol. 2022;5(12):807256. doi:10.3389/fphar.2021.807256.; https://www.epidemvac.ru/jour/article/view/1847Test

  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية